ScreenerHero

SPRCSciSparc Ltd. Ordinary Shares

NAS · US · Healthcare · Biotechnology · scisparc.com
6.695USDMkt Cap: 3.84M $P/E: 0.07

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agit…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap3.84M $
Enterprise Value480.73K $
Revenue (TTM)856.00K $
Gross Profit631.00K $
Net Income (TTM)-12.18M $
Revenue/Share6.893 USD
Last Price6.695 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees3
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.07
P/E (Forward)—
PEG—
EV/EBITDA-0.06
EV/Revenue0.56
P/S4.44
P/B0.57
EPS (TTM)98.07
EPS (Forward)—
52W Range
6.500100% of range6.695
52W High6.695 USD
52W Low6.500 USD
Profitability
Gross Margin73.71%
Oper. Margin-848.95%
EBITDA Margin0.00%
Profit Margin-1422.78%
ROE-287.31%
ROA-159.79%
Growth
Revenue Growth-34.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.14M $
CapEx (TTM)—
FCF Margin97.31%
FCF Yield21.70%
Net Debt-4.22M $
Net Debt/EBITDA0.50
Balance Sheet
Debt/Equity0.09
Current Ratio2.41
Quick Ratio2.13
Book Value/Sh11.60 USD
Cash/Share8.009 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:9
Split DateMar 4, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.573.24K
Float553.39K
Insiders0.00%
Institutions9.38%
Short Interest
Short Ratio0.1d
Short % Float6.62%
Short % Out.6.62%
Shares Short37.97K
Short (prev mo.)26.06K
Technical
SMA 506.362 (+5.2%)
SMA 2009.092 (-26.4%)
Beta2.45
S&P 52W Chg21.00%
Avg Vol (30d)2.48K
Avg Vol (10d)113.11K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—